Keloid lesions show increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy

Research output: Contribution to journal › Letter › peer-review

85 Scopus citations

Original language	English
Pages (from-to)	e161-e164
Journal	Journal of the European Academy of Dermatology and Venereology
Volume	34
Issue number	4
DOIs	https://doi.org/10.1111/jdv.16097
State	Published - 1 Apr 2020

Access to Document

@article{07e9597b7a384789ba40ce56246d4eaf,

title = "Keloid lesions show increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy",

author = "A. Diaz and K. Tan and H. He and H. Xu and I. Cueto and Pavel, \{A. B.\} and Krueger, \{J. G.\} and E. Guttman-Yassky",

year = "2020",

month = apr,

day = "1",

doi = "10.1111/jdv.16097",

language = "English",

volume = "34",

pages = "e161--e164",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Keloid lesions show increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy

AU - Diaz, A.

AU - Tan, K.

AU - He, H.

AU - Xu, H.

AU - Cueto, I.

AU - Pavel, A. B.

AU - Krueger, J. G.

AU - Guttman-Yassky, E.

PY - 2020/4/1

Y1 - 2020/4/1

UR - https://www.scopus.com/pages/publications/85076758393

U2 - 10.1111/jdv.16097

DO - 10.1111/jdv.16097

M3 - Letter

C2 - 31747457

AN - SCOPUS:85076758393

SN - 0926-9959

VL - 34

SP - e161-e164

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

IS - 4

ER -